8 of 20 patients have been completed in Hong Kong. They were having trouble finding 12 additional Hong Kong residents to be in the trial so they found a way to open it up to non-HK residents and the trial should resume soon.

The trial in China (at the Kunming Army Hospital) is ready to go. All 20 patients are approved and the hospital is completing the final test runs of cell importation from the US. IF everything goes as planned, the trial will be done in 2 months.

The reason I mentioned the ChinaSCINet trials is because we will use the safety data from these trials to apply to the FDA for approval to start the trials here. The first SCINetUSA trial will be at Brackenridge Hospital in Austin Texas. Dr. Young hopes to start at the end of '11/beginning of '12.